Ann Infect Dis Epidemiol | Volume 3, Issue 2 | Case Report | Open Access

Rash in an Extremely Low Birth Weight Infant

Stephen M Akers¹, Panitan Yossuck¹, Autumn S Kiefer¹, Michelle L Mitchell² and Kathryn S Moffett^3*

¹Department of Pediatrics, West Virginia University, USA
²Department of Infectious Diseases, Children’s Hospital of Wisconson-Milwaukee Campus, USA
³Department of Pediatrics, West Virginia University, USA

^*Correspondance to: Kathryn S Moffett 

Fulltext PDF

Abstract

Primary cutaneous aspergillosis (PCA) is one of several invasive fungal infections that have increased in incidence in the last four decades. We present a case of an extremely low birth weight infant born at 24 weeks gestation diagnosed with cutaneous aspergillosis, highlighting the risk factors and clinical findings associated with neonatal PCA. Additionally we discuss use of serum galactomannan testing as well as combination amphotericin B and voriconazole therapy. Early recognition of lesions characteristic of PCA is required to ensure prompt diagnosis and treatment, potentially preventing dissemination with favorable outcomes.

Keywords:

Primary cutaneous aspergillosis; Extremely low birth weight; Prematurity; Serum galactomannan, amphotericin; Voriconazole

Citation:

Akers SM, Yossuck P, Kiefer AS, Mitchell ML, Moffett KS. Rash in an Extremely Low Birth Weight Infant. Ann Infect Dis Epidemiol. 2018;3(2):1034.